| __timestamp | Amphastar Pharmaceuticals, Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 88806000000 |
| Thursday, January 1, 2015 | 251519000 | 107927000000 |
| Friday, January 1, 2016 | 255165000 | 111780000000 |
| Sunday, January 1, 2017 | 240175000 | 111696000000 |
| Monday, January 1, 2018 | 294666000 | 111831000000 |
| Tuesday, January 1, 2019 | 322357000 | 122021000000 |
| Wednesday, January 1, 2020 | 349846000 | 126946000000 |
| Friday, January 1, 2021 | 437768000 | 140800000000 |
| Saturday, January 1, 2022 | 498987000 | 176954000000 |
| Sunday, January 1, 2023 | 644395000 | 232261000000 |
| Monday, January 1, 2024 | 290403000000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, Novo Nordisk A/S and Amphastar Pharmaceuticals, Inc. have been key players. Over the past decade, Novo Nordisk has consistently outperformed Amphastar in terms of annual revenue. From 2014 to 2023, Novo Nordisk's revenue surged by approximately 161%, reaching a staggering $232 billion in 2023. In contrast, Amphastar's revenue grew by about 206%, yet it only reached $644 million in the same year.
While Amphastar's growth rate is impressive, Novo Nordisk's sheer scale and market dominance are evident. By 2023, Novo Nordisk's revenue was over 360 times that of Amphastar. This stark contrast highlights Novo Nordisk's stronghold in the industry, driven by its innovative diabetes care solutions and strategic market expansions.
Revenue Showdown: Eli Lilly and Company vs Amphastar Pharmaceuticals, Inc.
Novo Nordisk A/S or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Revenue Insights: Novo Nordisk A/S and Amneal Pharmaceuticals, Inc. Performance Compared
Novo Nordisk A/S vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared
R&D Insights: How Novo Nordisk A/S and Amphastar Pharmaceuticals, Inc. Allocate Funds
Novo Nordisk A/S vs Evotec SE: Examining Key Revenue Metrics
Who Generates More Revenue? AbbVie Inc. or Amphastar Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Amphastar Pharmaceuticals, Inc.
argenx SE and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Biogen Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Amphastar Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?